Cosmo Pharmaceuticals NV

WELCOME TO COSMO

Cosmo is a specialty pharmaceutical company that aims to become a global leader in the market of optimized therapies for selected gastro-intestinal diseases. The company’s proprietary clinical development pipeline specifically addresses innovative treatments for gastro-intestinal diseases.

 

 

 

Therapeutic Focus

Inflammatory Bowel Diseases (IBD) are a group of chronic, progressive, recurring and debilitating disorders characterized by severe damage of the gastro-intestinal tract.

UPCOMING EVENT

28/07/2017

Release of half year results 2017

Product Pipeline

Financial Data

Multimedia

Delivered by Investis – link to website (opens in a new window)